Calliditas Therapeutics (CALT)

40.00 ↑0.00 (0.00%)
As of August 28, 2024, 1:00pm EST.

CALT Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $15.79 - $41.55
  • Market Capitalization: $1.09B
  • Short Percentage: 0.02%
  • Target Price: $39.25
  • Shares Outstanding: 27.02M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
2022-02-24
Earnings

CALT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $16.47 Close: +8.74% Next Day: +12.33% Next Week: +0.61% View More
0 Comments Share
Help your fellow traders

Stock Details

  • Current Price: $40.00
  • 52-Week Low: $15.79
  • 52-Week High: $41.55
  • Most Recent Quarter: 2024-06-30
  • Shares Float: 676.75K
  • Shares Outstanding: 27.02M
  • Market Capitalization: $1.09B
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 0.02%

The short interest for Calliditas Therapeutics is at 0.02%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 95.87%
Insiders: 3.81%
Instutitions: 0.32%

Analyst Target Price

39.25

Calliditas Therapeutics is currently $0.75 above Wallstreet Analysts' price target.

Yesterday's Volume

9,796

Interest in Calliditas Therapeutics has been trending up. The average daily volume in the past 14 days is 7,684.

Discussions

Please log in or register to share your thoughts.

kairaae6/26/24 12:11pm

$CALT gonna take my L with this one

0 Like Report
wsb_pro4/30/24 07:32pm

$CALT come on I wana jump up and down

0 Like Report
delaina4/17/24 03:51pm

$CALT we need one good push to moon this.

0 Like Report
MyToiletBroke4/2/24 08:00am

$CALT wow
looking like it’s going to be a monster day!

0 Like Report
145zip3/16/24 10:20am

$CALT watch for another rejection up here

0 Like Report
4texin12/21/23 02:34pm

$CALT let’s gooooo

0 Like Report